Come up with a name for your new list and we'll add to it:
Cyteir Therapeutics raised a round of funding on June 29, 2016. Investors include
National Cancer Institute.
Cyteir Therapeutics is a research-stage biopharmaceutical company leveraging its expertise in DNA repair and genome instability to develop new targeted therapeutics for a range of human diseases, incl…